Craven Laboratories

Craven Laboratories was an American research and chemical-testing company based in Austin, Texas. It became known not for a commercial product portfolio, but for a major scientific-integrity and regulatory case involving allegedly falsified pesticide safety data. The company conducted testing used by chemical manufacturers seeking approval from the United States Environmental Protection Agency (EPA), and its work was connected to regulatory submissions for a large number of companies and chemicals. The EPA announced on March 1, 1991, that it was investigating Craven Laboratories over allegations that employees had falsified test data used by pesticide manufacturers to obtain or support EPA approvals. The investigation involved the EPA's Office of Prevention, Pesticides, and Toxic Substances, the United States Department of Justice Environmental Crimes Division, and the United States Attorney. The case was significant because Craven was described as the first chemical-testing laboratory charged in the United States after the establishment of the Food and Drug Administration's Good Laboratory Practices regulations. A federal grand jury indicted the laboratory's owner, Don Allen Craven, in 1991. The charges included conspiracy, mail fraud, making false statements, concealing material facts, and obstructing EPA proceedings. The head of the laboratory's Quality Assurance Unit and several laboratory technicians were also charged. The allegations concerned the reliability and integrity of studies submitted in support of pesticide regulatory decisions. The reported scope of the misconduct was substantial. At least 48 chemicals were approved on the basis of research associated with the fraudulent studies, and the Food and Drug Administration reported that Craven had performed safety analyses for 262 companies. Reference material also noted that 28 of the affected chemicals remained on the market in New Zealand in 1993, illustrating that the consequences of the testing extended beyond the United States regulatory process. On February 25, 1994, the Department of Justice announced that the president of Craven Laboratories and fourteen former employees had been adjudged guilty in connection with the falsification of research data. The investigation also generated private litigation: eleven multinational corporations filed lawsuits against Craven seeking recovery for losses attributed to the misconduct. Monsanto stated that an industry task force had first identified irregularities, prompting the EPA investigation; it also said that the relevant studies had been repeated and that Roundup's EPA certification no longer relied on studies from Craven Laboratories. Because the available reference material focuses almost entirely on the enforcement case, information about Craven Laboratories' founding, ordinary commercial operations, client services, productized offerings, ownership structure beyond Don Allen Craven, and ultimate corporate disposition is not established here. The company is therefore documented primarily as a historical chemical-testing and research organization associated with a landmark pesticide-data fraud case.

Craven Laboratories operated as a chemical research and testing laboratory in Austin, Texas, providing safety-analysis work for chemical companies. Its studies were used in the regulatory process for pesticides and other chemicals, particularly in connection with applications or approvals reviewed by the United States Environmental Protection Agency. The available historical record does not establish the company's founding date, original founders, detailed organizational structure, or full list of clients. The company entered the public record in 1991 when the EPA announced an investigation into alleged falsification of pesticide test data. According to the investigation account, the suspected manipulation involved research used by chemical manufacturers to obtain EPA approval. The inquiry was coordinated across environmental, justice, and prosecutorial authorities, including the EPA Office of Prevention, Pesticides, and Toxic Substances, the Department of Justice Environmental Crimes Division, and the United States Attorney. In the same year, a federal grand jury indicted owner and president Don Allen Craven. The indictment included charges of conspiracy, mail fraud, making false statements, concealing material facts, and obstructing EPA proceedings. The head of the laboratory's Quality Assurance Unit and several technicians were also charged. The case placed laboratory quality systems and the reliability of contract research under intense scrutiny. Craven was described as the first chemical-testing laboratory charged in the United States after the FDA's Good Laboratory Practices regulations had been established. The reported reach of the case extended beyond a single study. At least 48 chemicals had been approved on the basis of research associated with the fraudulent work. The FDA reported that Craven Laboratories had conducted safety analyses for 262 companies. Reference material further indicated that 28 of the affected chemicals were still marketed in New Zealand in 1993, demonstrating that regulatory consequences could persist across national markets after the original studies had been accepted. The enforcement process culminated in a Department of Justice announcement on February 25, 1994. The department stated that the president of Craven Laboratories and fourteen former employees had been adjudged guilty for falsifying research data. The case also led to civil litigation, with eleven multinational corporations suing Craven for losses allegedly caused by the misconduct. The record includes a response from Monsanto. The company said that an industry task force had discovered irregularities and that those findings prompted the EPA investigation. Monsanto also stated that the relevant studies had been repeated and that Roundup's EPA certification no longer depended on any Craven Laboratories studies. This response illustrates how affected chemical companies sought to distinguish their regulatory positions from the laboratory's alleged misconduct. No reliable source in the supplied material establishes whether Craven Laboratories formally dissolved, was acquired, or continued operating after the criminal proceedings. Its present status is therefore recorded as unknown. Historically, the company is chiefly important as an early and prominent example of alleged contract-laboratory fraud in pesticide regulation and as a case that reinforced the importance of Good Laboratory Practice controls, auditability, and independent verification of safety data.

• 1994

  Guilty judgments announced

  [1]Craven Laboratoriesen.wikipedia.org

  The Department of Justice announced that the laboratory's president and fourteen former employees had been adjudged guilty for falsifying research data.

• 1993

  Affected chemicals reported on the New Zealand market

  [1]Craven Laboratoriesen.wikipedia.org

  Reference material reported that 28 chemicals connected with the fraudulent research remained on the New Zealand market in 1993.

• 1991

  EPA opens investigation

  [1]Craven Laboratoriesen.wikipedia.org

  The EPA announced an investigation into allegations that Craven Laboratories had falsified pesticide test data used in chemical-approval submissions.

• 1991

  Federal indictments

  [1]Craven Laboratoriesen.wikipedia.org

  A federal grand jury indicted Don Allen Craven, the Quality Assurance Unit head, and several laboratory technicians on charges related to alleged research fraud and obstruction.

Chemical-testing and research laboratory serving pesticide and chemical manufacturers through safety and regulatory-support studies.

• Laboratory research service

  Chemical safety analyses

  Craven Laboratories performed safety-analysis work for chemical companies. These analyses formed part of the evidence used in regulatory submissions and approvals. The available record does not identify specific laboratory methods, analytical instruments, branded service packages, or individual study names.

• Pesticide testing service

  Pesticide regulatory-support studies

  The laboratory conducted research used by chemical manufacturers seeking EPA approval for pesticides. The historical case centers on allegations that data from some of these studies was falsified, so the record describes the service primarily through its regulatory role rather than as a consumer-facing product.

• 1994

  Criminal judgments against the president and former employees

  The Department of Justice announced that the president of Craven Laboratories and fourteen former employees had been adjudged guilty for falsifying research data.

  Source

• 1991

  Pesticide research-data falsification investigation

  The EPA investigated allegations that Craven Laboratories had falsified test results used by chemical companies to obtain pesticide approvals. The case involved federal environmental and criminal-enforcement authorities and became a prominent Good Laboratory Practice enforcement matter.

  Source

Read more

• 1994

  Convictions announced in research-fraud caseOther

  Background

  The Department of Justice concluded the criminal phase of the case concerning falsified research data.

  Action taken

  The department announced that the president and fourteen former employees had been adjudged guilty.

  Aftermath

  Eleven multinational corporations filed lawsuits against Craven for losses attributed to the misconduct. Monsanto said affected studies had been repeated and were no longer used for Roundup's EPA certification.

  • Monsanto — Monsanto stated that an industry task force had identified irregularities, that the studies had been repeated, and that Roundup's EPA certification no longer relied on Craven Laboratories studies.

  Source

• 1991

  Federal prosecution follows EPA investigationOther

  Background

  Regulators alleged that laboratory data used in pesticide-approval work had been falsified, prompting a coordinated EPA, Department of Justice, and United States Attorney investigation.

  Action taken

  Federal prosecutors obtained indictments against the owner, the Quality Assurance Unit head, and several technicians on multiple felony counts.

  Aftermath

  The case expanded into criminal judgments, regulatory scrutiny of affected chemicals, and civil litigation by multinational companies.

  Source

1. 1Craven Laboratoriesen.wikipedia.org